TD Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-31,494
| Closed | -$172K | – | 1389 |
|
|
2023
Q3 | $172K | Sell |
31,494
-33,491
| -52% | -$183K | ﹤0.01% | 1377 |
|
|
2023
Q2 | $436K | Sell |
64,985
-6,500
| -9% | -$43.6K | ﹤0.01% | 1294 |
|
|
2023
Q1 | $631K | Sell |
71,485
-19,634
| -22% | -$173K | ﹤0.01% | 1221 |
|
|
2022
Q4 | $696K | Hold |
91,119
| – | – | ﹤0.01% | 1217 |
|
|
2022
Q3 | $624K | Hold |
91,119
| – | – | ﹤0.01% | 1255 |
|
|
2022
Q2 | $737K | Hold |
91,119
| – | – | ﹤0.01% | 1232 |
|
|
2022
Q1 | $1.27M | Sell |
91,119
-88,953
| -49% | -$1.23M | ﹤0.01% | 1194 |
|
|
2021
Q4 | $5.05M | Buy |
180,072
+60,100
| +50% | +$1.69M | ﹤0.01% | 870 |
|
|
2021
Q3 | $4.08M | Buy |
119,972
+5,900
| +5% | +$201K | ﹤0.01% | 871 |
|
|
2021
Q2 | $4.18M | Buy |
114,072
+13,697
| +14% | +$502K | ﹤0.01% | 877 |
|
|
2021
Q1 | $4.04M | Buy |
100,375
+35,719
| +55% | +$1.44M | ﹤0.01% | 889 |
|
|
2020
Q4 | $3.82M | Buy |
64,656
+18,200
| +39% | +$1.08M | ﹤0.01% | 869 |
|
|
2020
Q3 | $2.26M | Hold |
46,456
| – | – | ﹤0.01% | 876 |
|
|
2020
Q2 | $2.25M | Buy |
46,456
+1,100
| +2% | +$53.2K | ﹤0.01% | 848 |
|
|
2020
Q1 | $1.26M | Buy |
45,356
+18,524
| +69% | +$515K | ﹤0.01% | 942 |
|
|
2019
Q4 | $803K | Buy |
26,832
+1,700
| +7% | +$50.9K | ﹤0.01% | 1146 |
|
|
2019
Q3 | $777K | Buy |
+25,132
| New | +$777K | ﹤0.01% | 1103 |
|